Pompe disease: from pathophysiology to therapy and back again
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
Pompe disease is a lysosomal storage disorder in which acid alpha-glucosidase (GAA) is deficient or absent. Deficiency of this lysosomal enzyme results in progressive expansion of glycogen-filled lysosomes in multiple tissues, with cardiac and skeletal muscle being the most severely affected. The clinical spectrum ranges from fatal hypertrophic cardiomyopathy and skeletal muscle myopathy in infants to relatively attenuated forms, which manifest as a progressive myopathy without cardiac involvement. The currently available enzyme replacement therapy (ERT) proved to be successful in reversing cardiac but not skeletal muscle abnormalities. Although the overall understanding of the disease has progressed, the pathophysiology of muscle damage remains poorly understood. Lysosomal enlargement/rupture has long been considered a mechanism of relentless muscle damage in Pompe disease. In past years, it became clear that this simple view of the pathology is inadequate; the pathological cascade involves dysfunctional autophagy, a major lysosome-dependent intracellular degradative pathway. The autophagic process in Pompe skeletal muscle is affected at the termination stage-impaired autophagosomal-lysosomal fusion. Yet another abnormality in the diseased muscle is the accelerated production of large, unrelated to ageing, lipofuscin deposits-a marker of cellular oxidative damage and a sign of mitochondrial dysfunction. The massive autophagic buildup and lipofuscin inclusions appear to cause a greater effect on muscle architecture than the enlarged lysosomes outside the autophagic regions. Furthermore, the dysfunctional autophagy affects the trafficking of the replacement enzyme and interferes with its delivery to the lysosomes. Several new therapeutic approaches have been tested in Pompe mouse models: substrate reduction therapy, lysosomal exocytosis following the overexpression of transcription factor EB and a closely related but distinct factor E3, and genetic manipulation of autophagy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing.
Kabeya, Y., Mizushima, N., Ueno, T., Yamamoto, A., Kirisako, T., Noda, T., Kominami, E., Ohsumi, Y., & Yoshimori, T. (2000) · The EMBO Journal · doi:10.1093/emboj/19.21.5720 · Cited by 6,605
Pankiv, S., Clausen, T. H., Lamark, T., Brech, A., Bruun, J.-A., Outzen, H., Øvervatn, A., Bjørkøy, G., & Johansen, T. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m702824200 · Cited by 4,578 · cited 1×
“The protein itself is a substrate for autophagy-mediated degradation; in addition, p62 can directly bind to LC3, thus connecting ubiquitinated (Ub) proteins which are destined for degradation and autophagic machinery (Pankiv et al., 2007; Bjørkøy et al., 2009).”
BackgroundMethods in Mammalian Autophagy Research
Mizushima, N., Yoshimori, T., & Levine, B. (2010) · Cell · doi:10.1016/j.cell.2010.01.028 · Cited by 4,497
Regulation mechanisms and signaling pathways of autophagy
He, C., & Klionsky, D. J. (2009) · Annual Review of Genetics · doi:10.1146/annurev-genet-102808-114910 · Cited by 3,609 · cited 1×
“…membrane; the major third form, most relevant to Pompe disease, is macroautophagy, which fulfils the role of supplying amino acids and energy under starvation by “selfdigestion” of intracellular components (Klionsky, 2007; He and Klionsky, 2009; Yang and Klionsky, 2010; Kaushik et al., 2011).”
BackgroundTFEB Links Autophagy to Lysosomal Biogenesis
Settembre, C., Di Malta, C., Polito, V. A., Arencibia, M. G., Vetrini, F., Erdin, S., Erdin, S. U., Huynh, T., Medina, D., Colella, P., et al. (2011) · Science · doi:10.1126/science.1204592 · Cited by 3,365 · cited 4×
“…lysosomal biogenesis and autophagy, has been shown to stimulate the generation of new lysosomes and autophagosomes, and to promote fusion of lysosomes with autophagosomes and plasma membrane in a variety of cell types (Sardiello et al., 2009; Settembre and Ballabio, 2011; Settembre et al., 2011).”
BackgroundInfluentialTranscriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546 · cited 1×
“A successful fiber type conversion was achieved by transgenic expression of PGC-1α—a transcription factor that promotes mitochondrial biogenesis and muscle remodeling (Lin et al., 2002)—in skeletal muscle of the GAA-KO mice.”
BackgroundA Gene Network Regulating Lysosomal Biogenesis and Function
Sardiello, M., Palmieri, M., di Ronza, A., Medina, D. L., Valenza, M., Gennarino, V. A., Di Malta, C., Donaudy, F., Embrione, V., Polishchuk, R. S., et al. (2009) · Science · doi:10.1126/science.1174447 · Cited by 2,543 · cited 3×
“…lysosomal biogenesis and autophagy, has been shown to stimulate the generation of new lysosomes and autophagosomes, and to promote fusion of lysosomes with autophagosomes and plasma membrane in a variety of cell types (Sardiello et al., 2009; Settembre and Ballabio, 2011; Settembre et al., 2011).”
BackgroundHomeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.
Komatsu, M., Waguri, S., Koike, M., Sou, Y.-S., Ueno, T., Hara, T., Mizushima, N., Iwata, J.-I., Ezaki, J., Murata, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.035 · Cited by 2,124 · cited 1×
“The protein accumulates in cells from autophagy-deficient mice (Komatsu et al., 2007), and an increase in the level of p62 is an indication of a functional deficiency of autophagy.”
BackgroundMammalian autophagy: core molecular machinery and signaling regulation
Yang, Z., & Klionsky, D. J. (2010) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.11.014 · Cited by 1,956 · cited 1×
“…membrane; the major third form, most relevant to Pompe disease, is macroautophagy, which fulfils the role of supplying amino acids and energy under starvation by “selfdigestion” of intracellular components (Klionsky, 2007; He and Klionsky, 2009; Yang and Klionsky, 2010; Kaushik et al., 2011).”
BackgroundZoncu, R., Bar-Peled, L., Efeyan, A., Wang, S., Sancak, Y., & Sabatini, D. M. (2011) · Science · doi:10.1126/science.1207056 · Cited by 1,673
Autophagy is required to maintain muscle mass.
Masiero, E., Agatea, L., Mammucari, C., Blaauw, B., Loro, E., Komatsu, M., Metzger, D., Reggiani, C., Schiaffino, S., & Sandri, M. (2009) · Cell Metabolism · doi:10.1016/j.cmet.2009.10.008 · Cited by 1,282 · cited 1×
“The loss of autophagy alone in skeletal muscle of wild type mice is associated with the accumulations of dysfunctional mitochondria, mild atrophy, and age-dependent decrease in muscle strength (Masiero et al., 2009; Wu et al., 2009; Masiero and Sandri, 2010).”
BackgroundBrunk, U. T., & Terman, A. (2002) · Free Radical Biology and Medicine · doi:10.1016/s0891-5849(02)00959-0 · Cited by 919 · cited 2×
“Bar: 10 µm. characteristic sign of cellular oxidative damage and aging (Brunk and Terman, 2002; Terman and Brunk, 2006; Terman et al., 2006).”
BackgroundRegulation of mTORC1 by amino acids
Bar-Peled, L., & Sabatini, D. M. (2014) · Trends in Cell Biology · doi:10.1016/j.tcb.2014.03.003 · Cited by 773 · cited 4×
“, Strigl-Pill, N., and Schoser, B. (2012). Toward deconstructing the phenotype of late-onset Pompe disease.”
BackgroundInfluentialTerman, A., Kurz, T., Navratil, M., Arriaga, E. A., & Brunk, U. T. (2010) · Antioxidants & Redox Signaling · doi:10.1089/ars.2009.2598 · Cited by 490 · cited 2×
“Lipofuscin is an autofluorescent lipopigment, which is composed of highly cross-linked undegradable protein aggregates, lipids, carbohydrates, and metals (particularly iron) (Terman et al., 2010).”
BackgroundAutophagy in lysosomal storage disorders
Lieberman, A. P., Puertollano, R., Raben, N., Slaugenhaupt, S., Walkley, S. U., & Ballabio, A. (2012) · Autophagy · doi:10.4161/auto.19469 · Cited by 399 · cited 2×
“, and Ballabio, A. (2011). TFEB regulates autophagy: an integrated”
BackgroundSelf-citationIsolation and Characterization of Rat Liver Amphisomes
Berg, T. O., Fengsrud, M., Strømhaug, P. E., Berg, T., & Seglen, P. O. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.34.21883 · Cited by 385
Raben, N., Hill, V., Shea, L., Takikita, S., Baum, R., Mizushima, N., Ralston, E., & Plotz, P. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn292 · Cited by 352 · cited 2×
“In addition, immunostaining of isolated muscle fibers showed that both the Ub-proteins and p62/SQSTM1 were seen within the autophagic areas, again indicating that the recycling process is inefficient in Pompe skeletal muscle (Raben et al., 2008; Shea and Raben, 2009).”
BackgroundSelf-citationTranscription factor EB (TFEB) is a new therapeutic target for Pompe disease
Spampanato, C., Feeney, E., Li, L., Cardone, M., Lim, J., Annunziata, F., Zare, H., Polishchuk, R., Puertollano, R., Parenti, G., et al. (2013) · EMBO Molecular Medicine · doi:10.1002/emmm.201202176 · Cited by 341 · cited 5×
“The in vitro model replicates lysosomal, but not autophagic pathology (see below) (Figure 1; Spampanato et al., 2013), and as such can be used to decipher the early events which precede the development of autophagic buildup—a hallmark of the disease in Pompe muscle fibers.”
BackgroundInfluentialSelf-citationAutophagy inhibition induces atrophy and myopathy in adult skeletal muscles
Masiero, E., & Sandri, M. (2010) · Autophagy · doi:10.4161/auto.6.2.11137 · Cited by 220
Neufeld, E. F., & Fratantoni, J. C. (1970) · Science · doi:10.1126/science.169.3941.141 · Cited by 215 · cited 2×
“…and internalize lysosomal enzymes, first demonstrated in cross-correction experiments, in which normal cells rescued the nearby deficient cells (Neufeld and Fratantoni, 1970), became the fundamental basis of enzyme replacement therapy (ERT) for lysosomal storage diseases, including Pompe…”
BackgroundSmith, B. K., Collins, S. W., Conlon, T. J., Mah, C. S., Lawson, L. A., Martin, A. D., Fuller, D. D., Cleaver, B. D., Clément, N., Phillips, D., et al. (2013) · Human Gene Therapy · doi:10.1089/hum.2012.250 · Cited by 158
Lysosomal adaptation: how the lysosome responds to external cues
Settembre, C., & Ballabio, A. (2014) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a016907 · Cited by 126 · cited 4×
“…this ability of lysosomes to exocytose is now seen as an integral part of the lysosomal function—to accomplish cellular Frontiers in Aging Neuroscience www.frontiersin.org July 2014 | Volume 6 | Article 177 | 9 clearance by degrading the cargo or by discharging it (Settembre and Ballabio, 2014).”
BackgroundInfluentialByrne, B. J., Falk, D. J., Pacak, C. A., Nayak, S., Herzog, R. W., Elder, M. E., Collins, S. W., Conlon, T. J., Clement, N., Cleaver, B. D., et al. (2011) · Human Molecular Genetics · doi:10.1093/hmg/ddr174 · Cited by 91
Takikita, S., Schreiner, C., Baum, R., Xie, T., Ralston, E., Plotz, P. H., & Raben, N. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015239 · Cited by 60 · cited 1×
“However, overexpression of PGC-1α in the diseased muscle failed to improve the ERT, mainly because of the considerable increase in the lysosomal glycogen load (Takikita et al., 2010).”
BackgroundSelf-citation
Cited by
Talbot, J., & Maves, L. (2016) · WIREs Developmental Biology · doi:10.1002/wdev.230 · Cited by 437
Lysosomes as coordinators of cellular catabolism, metabolic signalling and organ physiology
Settembre, C., & Perera, R. M. (2024) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-023-00676-x · Cited by 285
Glycogen Metabolism and Glycogen Storage Disorders
Kanungo, S., Wells, K., Tribett, T., & El-Gharbawy, A. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.59 · Cited by 200
Evaluating and mitigating the immunogenicity of therapeutic proteins
Sauna, Z. E., Lagassé, D., Pedras-Vasconcelos, J., Golding, B., & Rosenberg, A. S. (2018) · Trends in biotechnology · doi:10.1016/j.tibtech.2018.05.008 · Cited by 118
Biochemical and Clinical Aspects of Glycogen Storage Diseases
Ellingwood, S. S., & Cheng, A. (2018) · Journal of Endocrinology · doi:10.1530/joe-18-0120 · Cited by 118
Metadata
- Authors
- Lim, J.-A., Li, L., & Raben, N.
- Venue
- Frontiers in Aging Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2014-07-23
- Volume
- 6
- Pages
- 177-177
- ISSN
- 1663-4365 (ISSN-L)
- OpenAlex
- W2042974652
- Cited by
- 207
- References
- 24
- FWCI
- 10.30
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.